Watch, read and listen to topics that shape our world.
Our in-house experts share their thoughts and perspectives covering news, research and insights into the global economy.
![Painting of a bowl of fruit](/sites/default/files/styles/max_650x650/public/2024-05/08-23K6455-1920x1080.jpg?itok=LXYtQcw3)
Insatiable appetite for obesity drugs?
Why have obesity drugs captivated both the medical community and investors’ attention over the last two years?
![High or low graphic with pink and blue squares](/sites/default/files/styles/max_650x650/public/2024-05/CCLA-Hot-or-cold-744x436-insights.png?itok=1zwGvZFW)
Market barometer: July 2024
Each month our investment team provide a macro outlook into global investment markets.
![Abstract painting with red circle](/sites/default/files/styles/max_650x650/public/2024-07/04-20Kp1-1920x1080.jpg?itok=Y65ogVta)
Beyond the Magnificent 7
Here we discuss the Magnificent 7, why they have performed so well, and why we don’t own all these stocks at such high concentration in CCLA equity portfolios.
![Abstract image of a flower](/sites/default/files/styles/max_650x650/public/2024-05/02-17Kp98-1920x1080.jpg?itok=dVdfiXlv)
There could be over £30 billion of charitable funds which may not be earning the best rates of interest
CCLA reacts to findings by Broadstone independent charity consultancy firm.
![High or low graphic with pink and blue squares](/sites/default/files/styles/max_650x650/public/2024-05/CCLA-Hot-or-cold-744x436-insights.png?itok=1zwGvZFW)
Market barometer: June 2024
Each month our investment team provide a macro outlook into global investment markets.
![High or low graphic with pink and blue squares](/sites/default/files/styles/max_650x650/public/2024-05/CCLA-Hot-or-cold-744x436-insights.png?itok=1zwGvZFW)
Market barometer: May 2024
Each month our investment team provide a macro outlook into global investment markets.
![](/sites/default/files/styles/max_1300x1300/public/oembed_thumbnails/2024-04/lSiW1zeV8xo02J79DZpBKkWv1IMPWVP8q83bpHskTeM.jpg?itok=9MBIJz_B)